Récher, C., Hospital, M., Leguay, T., Carré, M., Orvain, C., Bonmati, C., Raffoux, E., Simand, C., Guieze, R., Frayfer, J., Lambert, J., Chantepie, S., Bernard, M., Peterlin, P., Alexis, M., Turlure, P., Pautas, C., Bertoli, S., Gabellier, L., Forcade, E., Duployez, N., Luquet, I., Penther, D., Celli-Lebras, K., Mineur, A., Gardin, C., Ifrah, N., Vey, N., Latour, R. P. D., Dumas, P., Delabesse, Ã., Preudhomme, C., Hamel, J., Dombret, H., Pigneux, A., Mathilde, H., Botton, S. D. (2025). Randomized study of high-dose cytarabine with or without dexamethasone as post-remission therapy in younger adults with newly diagnosed AML – the french backbone intergroup (BIG)-1 study on behalf of the filo, ALFA, and SFGM-TC study groups. Blood. https://doi.org/10.1182/blood-2025-881